natgillin/translations-raw huggingface dataset:
It is therefore appropriate to renew the approval of Coniothyrium minitans strain CON/M/91-08 as a low-risk substance.
Zato je primerno obnoviti odobritev Coniothyrium minitans, sev CON/M/91-08, kot snovi z majhnim tveganjem.
In accordance with Article 13(4) of Regulation (EC) No 1107/2009, the Annex to Implementing Regulation (EU) No 540/2011 should be amended accordingly.
V skladu s členom 13(4) Uredbe (ES) št. 1107/2009 je treba ustrezno spremeniti Prilogo k Izvedbeni uredbi (EU) št. 540/2011.
Commission Implementing Regulation (EU) 2016/950 [7] extended the approval period of Coniothyrium minitans strain CON/M/91-08 to 31 October 2017 in order to allow the renewal process to be completed before the expiry date of the approval of that substance.
Z Izvedbeno uredbo Komisije (EU) 2016/950 [7] je bilo podaljšano obdobje odobritve Coniothyrium minitans, sev CON/M/91-08, do 31. oktobra 2017, da bi se omogočil zaključek postopka obnovitve pred prenehanjem njegove odobritve.
However, given that a decision on renewal has been taken ahead of this extended expiry date, this Regulation shall apply from 1 August 2017.
Vendar ker je bil sklep o obnovitvi sprejet pred podaljšanim datumom prenehanja odobritve, bi se ta uredba morala uporabljati od 1. avgusta 2017.
The approval of the active substance Coniothyrium minitans strain CON/M/91-08, as specified in Annex I, is renewed subject to the conditions laid down in that Annex.
Odobritev aktivne snovi Coniothyrium minitans, sev CON/M/91-08, kot je opredeljena v Prilogi I, se obnovi pod pogoji iz navedene priloge.
Commission Directive 2003/79/EC of 13 August 2003 amending Council Directive 91/414/EEC to include Coniothyrium minitans as active substance (OJ L 205, 14.8.2003, p. 16).
Direktiva Komisije 2003/79/ES z dne 13. avgusta 2003 o spremembi Direktive Sveta 91/414/EGS z namenom uvrstitve Coniothyrium minitans na seznam aktivnih snovi (UL L 205, 14.8.2003, str. 16).
EFSA Journal 2016;14(7):4517, 16 pp.
EFSA Journal 2016; 14(7): 4517, str. 16.
Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (OJ L 159, 16.6.2016, p. 3).
Izvedbena uredba Komisije (EU) 2016/950 z dne 15. junija 2016 o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja obdobja odobritve aktivnih snovi 2,4-DB, beta-ciflutrin, karfentrazon-etil, Coniothyrium minitans sev CON/M/91–08 (DSM 9660), ciazofamid, deltametrin, dimetenamid-p, etofumesat, fenamidon, flufenacet, flurtamon, foramsulfuron, fostiazat, imazamoks, jodosulfuron, iprodion, izoksaflutol, linuron, malein hidrazid, mezotrion, oksasulfuron, pendimetalin, pikoksistrobin, siltiofam in trifloksistrobin (UL L 159, 16.6.2016, str. 3).
Coniothyrium minitans strain CON/M/91-08
Coniothyrium minitans, sev CON/M/91-08
Accession number in the culture collection of the ‘Deutsche Sammlung von Mikroorganismen’ (DSM), Germany: DSM 9660
Referenčna številka v zbirki kultur ‚Deutsche Sammlung von Mikroorganismen‘ (DSM), Nemčija: DSM 9660
CIPAC No 614
št.
Minimum content of viable spores:
Ni relevantno.
1 August 2017
Minimalna vsebina živih spor:
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Coniothyrium minitans strain CON/M/91-08, and in particular Appendices I and II thereof, shall be taken into account.
31. julij 2032
In this overall assessment Member States shall pay particular attention to:
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o obnovitvi Coniothyrium minitans, sev CON/M/91-08, ter zlasti dodatka I in II k poročilu.
the protection of operators and workers, taking into account that microorganisms are considered as potential sensitizers.
V tej celoviti oceni morajo biti države članice zlasti pozorne na:
Strict maintenance of environmental conditions and quality control analysis during the manufacturing process shall be assured by the producer.
varnost izvajalcev in delavcev ob upoštevanju, da mikroorganizmi lahko povzročajo preobčutljivost.
in Part A, entry 71 on Coniothyrium minitans strain CON/M/91-08 is deleted;
Priloga k Izvedbeni uredbi (EU) št. 540/2011 se spremeni:
in Part D, the following entry is added:
v delu A se vnos 71 za Coniothyrium minitans, sev CON/M/91-08, črta;
Number
v delu D se doda naslednji vnos:
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Coniothyrium minitans strain CON/M/91-08, and in particular Appendices I and II thereof, shall be taken into account.
Številka
Commission Implementing Regulation (EU) 2017/843
Izvedbena uredba Komisije (EU) 2017/843
approving the active substance Beauveria bassiana strain NPP111B005, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobritvi aktivne snovi Beauveria bassiana, sev NPP111B005, v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet in spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular Article 13(2) thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS [1] ter zlasti člena 13(2) Uredbe,
In accordance with Article 7(1) of Regulation (EC) No 1107/2009 France received on 6 November 2012 an application from Arysta Lifescience S.A.S. for the approval of the active substance Beauveria bassiana strain NPP111B005.
V skladu s členom 7(1) Uredbe (ES) št. 1107/2009 je Francija 6. novembra 2012 prejela zahtevek družbe Arysta Lifescience S.A.S. za odobritev aktivne snovi Beauveria bassiana, sev NPP111B005.
In accordance with Article 9(3) of that Regulation, France, as rapporteur Member State, notified the applicant, the other Member States, the Commission and the European Food Safety Authority (hereinafter ‘the Authority’) on 5 February 2013 of the admissibility of the application.
V skladu s členom 9(3) navedene uredbe je Francija kot država članica poročevalka 5. februarja 2013 obvestila vlagatelja, druge države članice, Komisijo in Evropsko agencijo za varnost hrane (v nadaljnjem besedilu: Agencija) o dopustnosti zahtevka.
On 7 October 2014 the rapporteur Member State submitted a draft assessment report to the Commission with a copy to the Authority, assessing whether that active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Država članica poročevalka je 7. oktobra 2014 Komisiji predložila osnutek poročila o oceni, pri čemer je en izvod poslala Agenciji, v katerem je ocenila, ali se za navedeno aktivno snov lahko pričakuje, da bo izpolnjevala merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009.
The assessment of the additional information by the rapporteur Member State was submitted to the Authority in the format of an updated draft assessment report on 3 July 2015.
Država članica poročevalka je 3. julija 2015 Agenciji predložila oceno dodatnih informacij v obliki posodobljenega osnutka poročila o oceni.
On 6 October 2015 the Authority communicated to the applicant, the Member States and the Commission its conclusion [2] on whether the active substance Beauveria bassiana strain NPP111B005 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Agencija je 6. oktobra 2015 vlagatelju, državam članicam in Komisiji poslala svoj sklep [2] o tem, ali se za aktivno snov Beauveria bassiana, sev NPP111B005, lahko pričakuje, da bo izpolnjevala merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009.
On 8 March 2016 the Commission presented to the Standing Committee on Plants, Animals, Food and Feed the review report for Beauveria bassiana strain NPP111B005 and a draft Regulation providing that Beauveria bassiana strain NPP111B005 is approved.
Komisija je 8. marca 2016 Stalnemu odboru za rastline, živali, hrano in krmo predložila poročilo o pregledu Beauveria bassiana, sev NPP111B005, in osnutek uredbe o odobritvi Beauveria bassiana, sev NPP111B005.
It is therefore appropriate to approve Beauveria bassiana strain NPP111B005.
Zato je primerno, da se Beauveria bassiana, sev NPP111B005, odobri.
The active substance Beauveria bassiana strain NPP111B005, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna snov Beauveria bassiana, sev NPP111B005, kot je opredeljena v Prilogi I, se odobri pod pogoji iz navedene priloge.
EFSA Journal 2015;13(10):4264 [34 pp.]. doi: 10.2903/j.efsa.2015.4264.
EFSA Journal 2015;13(10):4264 [34 str.]. doi: 10.2903/j.efsa.2015.4264.
Beauveria bassiana strain NPP111B005
Beauveria bassiana, sev NPP111B005
Accession number in the CNCM (Collection Nationale de Culture de Microorganismes) — Institut Pasteur, Paris, France: I-2961.
Referenčna številka v zbirki CNCM (Collection Nationale de Culture de Microorganismes) – Institut Pasteur, Pariz, Francija: I-2961.
Max. level of beauvericin 24 μg/L
Najvišja vsebnost beauvericina: 24 μg/L
7 June 2017
7. junij 2017
7 June 2027
7. junij 2027
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain NPP111B005, and in particular Appendices I and II thereof, shall be taken into account.
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu Beauveria bassiana, sev NPP111B005, ter zlasti dodatka I in II k poročilu.
the protection of operators and workers, taking into account that Beauveria bassiana strain NPP111B005 is to be considered, as any micro-organism, as a potential sensitizer, and paying special attention to exposure through inhalation,
zaščito izvajalcev in delavcev, ob upoštevanju, da lahko Beauveria bassiana, sev NPP111B005, tako kot vsi mikroorganizmi povzroča preobčutljivost, ter na izpostavljenost z vdihavanjem;
Commission Implementing Regulation (EU) 2017/844
Izvedbena uredba Komisije (EU) 2017/844
Regulation (EU) 2017/850 of the European Parliament and of the Council
Uredba (EU) 2017/850 Evropskega parlamenta in Sveta
amending Regulation (EC) No 539/2001 listing the third countries whose nationals must be in possession of visas when crossing the external borders and those whose nationals are exempt from that requirement (Ukraine)
o spremembi Uredbe (ES) št. 539/2001 o seznamu tretjih držav, katerih državljani morajo pri prehodu zunanjih meja imeti vizume, in držav, katerih državljani so oproščeni te zahteve (Ukrajina)
Council Regulation (EC) No 539/2001 [2] lists the third countries whose nationals must be in possession of a visa when crossing the external borders of the Member States and those whose nationals are exempt from that requirement.
V Uredbi Sveta (ES) št. 539/2001 [2] so navedene tretje države, katerih državljani morajo pri prehodu zunanjih meja držav članic imeti vizume, in države, katerih državljani so oproščeni te zahteve.
The composition of the lists of third countries in Annexes I and II should be, and should remain, consistent with the criteria set out in Regulation (EC) No 539/2001.
Sestava seznamov tretjih držav v prilogah I in II bi morala biti in ostati skladna z merili iz Uredbe (ES) št. 539/2001.
References to third countries in respect of which the situation has changed as regards those criteria should be transferred from one annex to the other, as appropriate.
Navedbe tretjih držav, v katerih je glede teh meril prišlo do sprememb, bi bilo treba ustrezno prenesti iz ene priloge v drugo.
It is considered that Ukraine has met all the benchmarks set out in the Visa Liberalisation Action Plan presented to the Ukrainian Government in November 2010, and therefore fulfils the relevant criteria for its citizens to be exempted from the visa requirement when travelling to the territory of Member States.
Za Ukrajino velja, da je izpolnila vsa merila iz akcijskega načrta za liberalizacijo vizumskega režima, ki je bil ukrajinski vladi predstavljen novembra 2010, in zato izpolnjuje ustrezna merila za izvzetje njenih državljanov iz vizumske obveznosti, ko potujejo na ozemlje držav članic.
The continuous fulfilment by Ukraine of such criteria, especially on the fight against organised crime and corruption, will be duly monitored by the Commission in accordance with the relevant mechanism set out in Regulation (EC) No 539/2001.
Komisija bo v skladu z ustreznim mehanizmom iz Uredbe (ES) št. 539/2001 skrbno spremljala, ali Ukrajina še naprej izpolnjuje ta merila, zlasti kar zadeva boj proti organiziranemu kriminalu in korupciji.
The reference to Ukraine should thus be transferred from Annex I to Regulation (EC) No 539/2001 to Annex II thereto.
Navedbo Ukrajine bi bilo zato treba prenesti iz Priloge I k Uredbi (ES) št. 539/2001 v Prilogo II k navedeni uredbi.
That visa waiver should apply only to holders of biometric passports issued by Ukraine in line with the standards of the International Civil Aviation Organisation (ICAO).
To izvzetje iz vizumske obveznosti bi moralo veljati le za imetnike biometričnih potnih listov, izdanih s strani Ukrajine v skladu s standardi Mednarodne organizacije civilnega letalstva (ICAO).
This Regulation constitutes a development of the provisions of the Schengen acquis in which the United Kingdom does not take part, in accordance with Council Decision 2000/365/EC [3]; the United Kingdom is therefore not taking part in the adoption of this Regulation and is not bound by it or subject to its application.
Ta uredba predstavlja razvoj določb schengenskega pravnega reda, pri katerih Združeno kraljestvo v skladu s Sklepom Sveta 2000/365/ES [3] ne sodeluje; Združeno kraljestvo torej ne sodeluje pri sprejetju te uredbe, ki zato zanj ni zavezujoča in se v njem ne uporablja.
This Regulation constitutes a development of the provisions of the Schengen acquis in which Ireland does not take part, in accordance with Council Decision 2002/192/EC [4]; Ireland is therefore not taking part in the adoption of this Regulation and is not bound by it or subject to its application.
Ta uredba predstavlja razvoj določb schengenskega pravnega reda, pri katerih Irska v skladu s Sklepom Sveta 2002/192/ES ne sodeluje [4]; Irska torej ne sodeluje pri sprejetju te uredbe, ki zato zanjo ni zavezujoča in se v njej ne uporablja.
As regards Iceland and Norway, this Regulation constitutes a development of the provisions of the Schengen acquis within the meaning of the Agreement concluded by the Council of the European Union and the Republic of Iceland and the Kingdom of Norway concerning the latters' association with the implementation, application and development of the Schengen acquis [5] which fall within the area referred to in Article 1, Point B of Council Decision 1999/437/EC [6].
Ta uredba za Islandijo in Norveško predstavlja razvoj določb schengenskega pravnega reda v smislu Sporazuma med Svetom Evropske unije in Republiko Islandijo ter Kraljevino Norveško o pridružitvi obeh k izvajanju, uporabi in razvoju schengenskega pravnega reda [5], ki spadajo na področje iz točke B člena 1 Sklepa Sveta 1999/437/ES [6].
As regards Switzerland, this Regulation constitutes a development of the provisions of the Schengen acquis within the meaning of the Agreement between the European Union, the European Community and the Swiss Confederation on the Swiss Confederation's association with the implementation, application and development of the Schengen acquis [7], which fall within the area referred to in Article 1, point B of Decision 1999/437/EC read in conjunction with Article 3 of Council Decision 2008/146/EC [8].
Ta uredba za Švico predstavlja razvoj določb schengenskega pravnega reda v smislu Sporazuma med Evropsko unijo, Evropsko skupnostjo in Švicarsko konfederacijo o pridružitvi Švicarske konfederacije k izvajanju, uporabi in razvoju schengenskega pravnega reda [7], ki spadajo na področje iz točke B člena 1 Sklepa 1999/437/ES v povezavi s členom 3 Sklepa Sveta 2008/146/ES [8].
As regards Liechtenstein, this Regulation constitutes a development of the provisions of the Schengen acquis within the meaning of the Protocol between the European Union, the European Community, the Swiss Confederation and the Principality of Liechtenstein on the accession of the Principality of Liechtenstein to the Agreement between the European Union, the European Community and the Swiss Confederation on the Swiss Confederation's association with the implementation, application and development of the Schengen acquis [9], which fall within the area referred to in Article 1, point B of Decision 1999/437/EC read in conjunction with Article 3 of Council Decision 2011/350/EU [10],
Ta uredba za Lihtenštajn predstavlja razvoj določb schengenskega pravnega reda v smislu Protokola med Evropsko unijo, Evropsko skupnostjo, Švicarsko konfederacijo in Kneževino Lihtenštajn o pristopu Kneževine Lihtenštajn k Sporazumu med Evropsko unijo, Evropsko skupnostjo in Švicarsko konfederacijo o pridružitvi Švicarske konfederacije k izvajanju, uporabi in razvoju schengenskega pravnega reda [9], ki spadajo na področje iz točke B člena 1 Sklepa 1999/437/ES v povezavi s členom 3 Sklepa Sveta 2011/350/EU [10] –
Regulation (EC) No 539/2001 is amended as follows:
Uredba (ES) št. 539/2001 se spremeni:
in Annex I, Part 1 (‘STATES’), the reference to Ukraine is deleted.
v delu 1 („DRŽAVE“) Priloge I se navedba Ukrajine črta;
in Annex II, Part 1 (‘STATES’), the following reference is inserted:
v delu 1 („DRŽAVE“) Priloge II se doda naslednja navedba:
‘UkraineArticle 2
„UkrajinaČlen 2
Position of the European Parliament of 6 April 2017 (not yet published in the Official Journal) and decision of the Council of 11 May 2017.
Stališče Evropskega parlamenta z dne 6. aprila 2017 (še ni objavljeno v Uradnem listu) in odločitev Sveta z dne 11. maja 2017.
The visa waiver is limited to the holders of biometric passports issued by Ukraine in line with standards of the International Civil Aviation Organisation (ICAO).’.
Izvzetje iz vizumske obveznosti je omejeno na imetnike biometričnih potnih listov, izdanih s strani Ukrajine v skladu s standardi Mednarodne organizacije civilnega letalstva (ICAO).“.
Regulation (EU) 2017/852 of the European Parliament and of the Council
Uredba (EU) 2017/852 Evropskega parlamenta in Sveta
on mercury, and repealing Regulation (EC) No 1102/2008
o živem srebru in razveljavitvi Uredbe (ES) št. 1102/2008
Mercury is a very toxic substance which represents a global and major threat to human health, including in the form of methylmercury in fish and seafood resources, ecosystems and wildlife.
Živo srebro je zelo strupena snov, ki predstavlja globalno in resno nevarnost za zdravje ljudi (med drugim v obliki metiliranega živega srebra v ribah in morskih sadežih), ekosisteme ter prostoživeče živali in rastline.
Due to the transboundary nature of mercury pollution, between 40 % and 80 % of total mercury deposition in the Union originates from outside the Union.
Zaradi čezmejne narave onesnaževanja z živim srebrom med 40 % in 80 % vsega živega srebra v odlagališčih v Uniji izvira iz držav zunaj Unije.
Action is therefore warranted at local, regional, national and international levels.
Zato je potrebno ukrepanje na lokalni, regionalni, nacionalni in mednarodni ravni.
Most mercury emissions and associated exposure risks result from anthropogenic activities such as primary mercury mining and processing, the use of mercury in products and industrial processes, artisanal and small-scale gold mining and processing, coal combustion and the management of mercury waste.
Večina tveganj, povezanih z emisijami živega srebra in izpostavljenostjo živemu srebru, je posledica antropogenih dejavnosti, kot so primarni izkop in pridobivanje živega srebra, uporaba živega srebra v proizvodih in industrijskih postopkih ter pri obrtniškem kopanju in pridobivanju zlata ter kopanju in pridobivanju zlata v majhnem obsegu, zgorevanje premoga in ravnanje z odpadki z živim srebrom.
The Seventh Environment Action Programme adopted by Decision No 1386/2013/EU of the European Parliament and of the Council [3] establishes the long-term objective of a non-toxic environment and, for that purpose, stipulates that action is needed to ensure the minimisation of significant adverse effects of chemicals on human health and the environment by 2020.
Sedmi okoljski akcijski program, sprejet s Sklepom št. 1386/2013/EU Evropskega parlamenta in Sveta [3], določa dolgoročni cilj nestrupenega okolja in navaja, da so v ta namen potrebni ukrepi, ki bodo do leta 2020 zagotovili zmanjšanje znatnih škodljivih vplivov kemikalij na zdravje ljudi in okolje.
The Communication of 28 January 2005 from the Commission to the European Parliament and the Council entitled ‘Community Strategy Concerning Mercury’, as reviewed on 7 December 2010 (‘the Strategy’), aims at minimising and, where feasible, ultimately eliminating global anthropogenic mercury releases to air, water and land.
Cilj sporočila Komisije z dne 28. januarja 2005 Evropskemu parlamentu in Svetu z naslovom „Strategija Skupnosti za živo srebro“, kakor je bilo revidirano leta 7. decembra 2010 (v nadaljnjem besedilu: Strategija), je čim večje zmanjšanje in, če je to izvedljivo, odprava svetovnih antropogenih izpustov živega srebra v zrak, vodo in zemljo.
In the past 10 years, significant progress has been achieved in the Union in the field of mercury management following the adoption of the Strategy and of a wide range of measures concerning mercury emissions, supply, demand and use, and the management of mercury surplus and stocks.
V Uniji je bil po sprejetju Strategije in različnih ukrepov glede emisij, ponudbe, povpraševanja in uporabe živega srebra ter glede upravljanja presežka in zalog živega srebra v zadnjih 10 letih dosežen velik napredek.
The Strategy recommends that the negotiation and conclusion of an international legally-binding instrument on mercury should be a priority as Union action alone cannot guarantee effective protection of the citizens of the Union against the negative health effects of mercury.
Strategija priporoča, da bi morala biti pogajanja in sklenitev mednarodnega pravno zavezujočega instrumenta o živem srebru prednostna naloga, saj ukrepi na ravni Unije sami ne morejo zagotoviti učinkovitega varstva državljanov Unije pred negativnimi zdravstvenimi vplivi živega srebra.
The Union and 26 Member States have signed the Minamata Convention on Mercury of 2013 (‘the Convention’).
Unija in 26 držav članic so podpisale Konvencijo Minamata o živem srebru (v nadaljnjem besedilu: Konvencija).
The two Member States that did not sign the Convention, Estonia and Portugal, have expressed their commitment to ratify it.
Državi članici, ki Konvencije nista podpisali, tj. Estonija in Portugalska, sta se zavezali, da jo bosta ratificirali.
The Union and all its Member States are therefore committed to its conclusion, transposition and implementation.
Unija in vse njene države članice so zato zavezane k njenemu sprejetju, prenosu in izvajanju.